Last $33.00 USD
Change Today +1.25 / 3.94%
Volume 2.5M
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gordon G. Pugh

Chief Operating Officer, Chief Risk Officer and Senior Vice President, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$1,965,724
As of Fiscal Year 2012

Background*

Mr. Gordon G. Pugh has been the Chief Operating Officer and Senior Vice President of Alkermes, Inc., since May 22, 2007 and serves as its Chief Risk Officer. Mr. Pugh is responsible for leading all areas related to the quality manufacture of products, management of supply chains, and operation of Alkermes sites. Mr. Pugh served as Vice President, Operations of Alkermes Inc. since 2002. He has BS in Microbiology from Cornell University and an MBA from Northeastern University. ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Cornell University
MBA
Northeastern University

Other Affiliations*

Annual Compensation*

Salary$437,493
Total Annual Compensation$437,493

Stock Options*

Restricted Stock Awards$271,575
All Other Compensation$8,575
Exercised Options69,550
Exercised Options Value$697,862
Exercisable Options383,750
Exercisable Options Value$1,703,670
Unexercisable Options227,150
Unexercisable Options Value$1,045,829
Total Value of Options$3,447,361
Total Number of Options680,450

Total Compensation*

Total Annual Cash Compensation$756,068
Total Short Term Compensation$437,493
Other Long Term Compensation$280,150
Total Calculated Compensation$1,965,724
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $33.00 USD +1.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$807.7K
N. Anthony Coles M.D., M.P.H.Chairman, Chief Executive Officer and President
Onyx Pharmaceuticals, Inc.
$740.0K
John H. Johnson Executive Chairman, Chief Executive Officer and President
Dendreon Corp.
$736.4K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee
Spectrum Pharmaceuticals, Inc.
$2.4M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$722.2K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.